Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Mepolizumab/omalizumab

Various toxicities: 4 case report

    • 3 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Sousa J, et al. Biological therapy-associated adverse reactions in asthma: analysis of reporting to the Portuguese pharmacovigilance system. Expert Opinion on Drug Safety 19: 99-106, No. 1, Jan 2020. Available from: URL: http://doi.org/10.1080/14740338.2020.1686481

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Mepolizumab/omalizumab. Reactions Weekly 1791, 166 (2020). https://doi.org/10.1007/s40278-020-75011-9

    Download citation